This invention is for the compound 17&bgr;-(N-t-butylcarbamoyl) -4-aza- 5&agr;-androst-1-en-3-one, pharmaceutical compositions containing the compound, methods of inhibiting testosterone 5&agr;-reductase with the compound and methods of treating hyperandrogenic conditions with the compound, particularly benign prostatic hypertrophy.
展开▼